Infographic: Changes in amphetamine residues from wastewater analyses in 29 European cities during the first lockdown period compared with before the pandemic (left) and after the first lockdown period (right)

Originally published in:

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
Figure 9, page 13

Main subject

prevalence and patterns of drug use

Keywords

amphetamine
COVID-19
methodology
prevalence and patterns of drug use
trendspotter study
wastewater analysis

Target audience

policymaker
researcher

Media type:

infographics

Published date:

April 2021
Some rights reserved (attribution, no derivatives, non-commercial)
Download (0.19 MB)

Related assets in the Media library

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%
At a glance — estimates of drug use in the European Union (updated June 2021)
Infographics: Changes in the mean weekly amounts of methamphetamine residues from wastewater analyses in selected European cities between 2019 and 2020
Infograpic: Proportion of all amphetamine samples submitted for testing to drug-checking services containing only the expected substance (amphetamine) in nine European cities in 2019 and 2020
Figure 8 showing Changes in the mean weekly amounts of amphetamine residues from wastewater analyses in selected European cities between 2019 and 2020
Infographic: Changes in the mean weekly amounts of amphetamine residues from wastewater analyses in selected European cities between 2019 and 2020
infographic showing residues of different drugs found in syringes from selected European cities, 2019
Drug residues in used syringes in selected European cities, 2019
Graphic showing the percentage of syringes by detected drug group, by site in Helsinki, for the 2017 pilot study of the ESCAPE project.
Percentage of syringes by detected drug group, by site, Helsinki, ESCAPE study 2017

Media library

Loading